What is Reputation Management?
In a world that revolves increasingly around the internet, most people and companies will have online profiles, whether they are on professional networks (such as LinkedIn, Viadeo) or social networks (Facebook, G+), and write their own blogs or have their own website. Everything we post, from articles and opinions, to photos and videos, is forging an online “reputation”. Continue reading
The Hospital Acquired Infection (HAI) space is growing both in size and new competitors. Abacus Diagnostica just announced the results of a new study demonstrating comparable sensitivity and specificity to the gold standard of culture-based testing and Cepheid’s GeneXpert C. difficile test. In addition to Cepheid, there are numerous other competitors in the HAI segment including BD, Quidel, Meridian, Nanosphere and other companies have C. difficile and Methicillin Resistant Staph Aureus (MRSA) tests under development. Continue reading
According to leading experts, there are over 3,000 Laboratory Developed Tests (LDTs) marketed in the US. LDTs are tests developed by large, medium, small and specialized clinical labs such as Quest Diagnostics, LabCorp, Myriad Genetics, Genomic Health, Sequenom and many others. LDTs play an import role in health care, especially in delivering molecular diagnostic and genetic screening results and interpretation to clinicians. To date, there is no single registry source to track existing LDTs and they continue to grow as labs deploy these high cost and high margin tests as rapid go-to-market strategies, since they do not require lengthy clinical trials and FDA approval. Now, the FDA has announced its intent to regulate LDTs. Continue reading
By the time you were two years old, almost all of the fat cells in your body were formed. Once created, it is the evolutionary goal of these cells to remain filled. Before and soon after you were born, the food industry impacted your predisposition for obesity through the diet of your mother, milk formula solutions, and store-bought baby food. After heightening the weight-loss struggle of the 69% of Americans over age 20 that are overweight, a new segment of the food industry is trying to fix the problem, racking in enormous profits in the process. Continue reading
In 2010, Procter & Gamble opened a pop-up store in Manhattan that attracted over 14,000 visits in ten days from curious customers. The success of this model has led to pop-up stores being viewed more and more as a way of advertising in a more interactive way than what television or print can offer. Continue reading
Kenya beat U.S. to it. The country where mega corporations like Apple, Google, and Wal-Mart were born was left in the dust by an economy a fraction of its size. The US and other developed countries are now scrambling to take hold of a technology that has been enjoyed by Kenyans for years. The ability to pay with cell phones is an industry that involves two-thirds of Kenya’s adult population and makes up a fourth of the country’s GDP. Continue reading
Commercial Reference Labs (CRLs) play an essential role in the delivery of heathcare. The largest companies in this segment are two well-known competitors Quest Diagnostics (NYSE: DGX) and LabCorp (NYSE: LH). Also competing in the reference lab market are smaller companies such as Bio-Reference Laboratories (BRLI), ARUP Laboratories and specialty companies with different go to market business models such as Myriad Genetics (NASDAQ: MYGN) and Genomic Health (NASDAQ: GHDX). Rounding out the market are100-250 small labs that focus on providing testing services to nursing homes and other alternate site care facilities and hospital labs that have their own outreach testing programs. Clinical lab test results account for over 70% of all clinical decisions according to leading industry experts, which highlights the importance of these companies in the healthcare continuum. Continue reading
There are approximately 240,000 men diagnosed with prostate cancer in the US each year and 30,000 will die from the disease. According to the National Institutes of Health, prostate cancer costs associated with prostate cancer were $12 billion in 2010.
In order to attempt to diagnose prostate cancer as early as possible, 23 million men are tested for the Prostate Specific Antigen (PSA) each year and 1 million have prostate biopsies for analysis by pathologists to determine if the biopsy is benign or cancerous. Continue reading
Pink slime in the United States, horse meat in beef products in Europe, fake eggs in China: 2012 was not short on global food scandals, which shook the food and retail industry. With growing uncertainty and distrust towards large multinationals, could increasing awareness about the origins of what we eat change the face of the food retail industry? Continue reading
Clinical diagnostic tests used to assist in the diagnosis, monitoring and patient therapeutic treatment strategies for a variety of disease states is essential to healthcare delivery. According to several leading opinion and industry sources, over 70% of all clinical decisions are based on a diagnostic test result. Yet this critical healthcare component consumes less than 3% of the annual healthcare spend in the US. The true value of this market remains largely unappreciated by several healthcare stakeholders. Continue reading